PRAGUE, Czech Republic — Upheal, a pioneering Czech mental health startup, has successfully raised €9.52 million (approximately $10 million) in its Series A funding round. The round was led by Headline, with participation from Credo Ventures and Kaya Ventures. This latest investment brings Upheal’s total funding to €13.65 million since its inception.
Founded in 2021, Upheal is transforming mental health care with its AI-powered platform designed to support clinicians. The platform enhances the therapeutic process by streamlining administrative tasks such as note-taking and session transcription, enabling secure video calls, and organizing data into summaries and analytics to help clinicians save time and improve patient care.
Improving Access and Efficiency in Mental Health Care
The company’s CEO, Juraj Chrappa, drew inspiration for Upheal from his own personal experiences, recognizing the critical need for better access to mental health support. The startup was co-founded by Chrappa and Martin Horváth, both Slovaks living in the Czech Republic, with the vision of improving the tools available to mental health professionals and enhancing the overall therapy experience.
“We founded Upheal with the goal of making mental health care more accessible and efficient for both clinicians and patients,” Chrappa said. “By leveraging AI to automate time-consuming tasks, we aim to give therapists more time to focus on what truly matters: providing high-quality care.”
A Growing Demand for Innovative Mental Health Solutions
Upheal’s platform is part of a growing trend in mental health technology, where AI is used to support mental health professionals and improve patient outcomes. With the new funding, the company plans to expand its platform’s capabilities and accelerate growth to meet the rising demand for mental health services worldwide.
Upheal’s innovative approach to mental health support has garnered attention from both investors and clinicians alike, offering a scalable solution for improving care delivery in a sector increasingly challenged by growing demand and clinician burnout.
